共 50 条
- [21] The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-γ growth inhibition of human breast carcinoma cell linesJOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2003, 23 (09): : 501 - 511Yim, JHRo, SHLowney, JKWu, SJConnett, JDoherty, GM
- [22] Immune modulatory cancer vaccines against IDO1 and PD-L1 trigger distinct pathways and cooperatively reduce tumor growth in preclinical modelsCANCER RESEARCH, 2024, 84 (06)Chapellier, MarionMartinenaite, EvelinaPatel, PreeyamSvendsen, LeaAhmad, Shamaila MunirGlockner, Hannah JorindeCarretta, MarcoSutanto-Ward, ErikaDuHadaway, JamesDey, SouvikShen, Shih-ChunGhaban, DemaIglesias, MarcosBiller, MeganLecoq, InesMuller, Alexander J.Andersen, Mads HaldPedersen, Ayako Wakatsuki
- [23] Neutralizing human IFN-ß combined with anti-human PD-L1 and antihuman CTLA-4 treatment increased control of endometrial tumor growth in a novel HLA-A matched BLT humanized miceCANCER RESEARCH, 2024, 84 (06)Yuan, ZheZu, GuoruiSun, XiaoPapasavvas, EmmanouilLu, LilyCassel, JoelLutes, Peter L.Cadungog, MarkSalvino, JosephMontaner, Luis J.
- [24] Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and MelanomaCANCER RESEARCH, 2016, 76 (23) : 6964 - 6974Clark, Curtis A.Gupta, Harshita B.Sareddy, GangadharaPandeswara, SrilakshmiLao, ShunhuaYuan, BinDrerup, Justin M.Padron, AlvaroConejo-Garcia, JoseMurthy, KruthiLiu, YangTurk, Mary JoThedieck, KathrinHurez, VincentLi, RongVadlamudi, RatnaCuriel, Tyler J.
- [25] Beta cell extracellular vesicle surface PD-L1 is induced by IFN-α treatment and correlates with residual C-peptide in plasma of children with recent-onset type 1 diabetesDIABETOLOGIA, 2024, 67 : S38 - S39Sims, E.Rao, C.Cater, D.Xu, J.De Olivera, A.Evans-Molina, C.Eizirik, D.Mirmira, R.
- [26] MEK-1 inhibitor PD098059 potentiates apoptosis and growth inhibition induced by interferon α (IFNα) in human epidermoid cancer cells.CLINICAL CANCER RESEARCH, 2000, 6 : 4545S - 4545SCaraglia, MTagliaferri, PTassone, PGiuberti, GMarra, MPepe, SBudillon, ADiGennaro, EBlanco, ARAbbruzzese, AVenuta, S
- [27] PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)Angelicola, StefaniaGiunchi, FrancescaRuzzi, FrancescaFrascino, MariateresaPitzalis, MaryScalambra, LauraSemprini, Maria SofiaPittino, Olga MariaCappello, ChiaraSiracusa, IreneChillico, Ilaria CandidaDi Noia, MartinaTurato, CristianDe Siervi, SilviaLescai, FrancescoCiavattini, TeresaLopatriello, GiuliaBertoli, LucaDe Jonge, HugoIamele, LuisaAltimari, AnnalisaGruppioni, ElisaArdizzoni, AndreaRossato, MarziaGelsomino, FrancescoLollini, Pier-LuigiPalladini, Arianna
- [28] PD-L1-expressing B cells promote murine breast cancer development and mediate the response to anti-PD-L1 immune checkpoint inhibitor to upregulate B-cell CD86 and inhibit tumor growth.CANCER RESEARCH, 2021, 81 (13)Khan, Mustafa T.Cervantes, ChristianLiu, ZexuanViswanadhapalli, SuryavathiGupta, HarshitaCuriel, TylerVadlamudi, RatnaXu, Zhenming
- [29] Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancerExperimental & Molecular Medicine, 2019, 51 : 1 - 13Dong Ha KimHyeongRyul KimYun Jung ChoiSeon Ye KimJung-Eun LeeKi Jung SungYoung Hoon SungChan-Gi PackMin-kyo JungBuhm HanKunhee KimWoo Sung KimSoo Jeong NamChang-Min ChoiMiyong YunJae Cheol LeeJin Kyung Rho
- [30] miR-140-3p Suppresses Cell Growth And Induces Apoptosis In Colorectal Cancer By Targeting PD-L1ONCOTARGETS AND THERAPY, 2019, 12 : 10275 - 10285Jiang, WeiLi, TaoWang, JingjingJiao, RuonanShi, XiaoHuang, XiaodanJi, Guozhong